Risk of malignancy in serous cystic neoplasms of the pancreas

Keyphrases

• Risk of Malignancy 100%
• Cystic Tumors of the Pancreas 100%
• Serous Cystic Neoplasm 100%
• Primary Tumor 33%
• Malignant Potential 33%
• Serous 33%
• Metachronous Metastasis 33%
• Serous Cystadenocarcinoma 33%
• Tumor 16%
• Immunohistochemical Analysis 16%
• Clinical Features 16%
• Malignancy 16%
• Clinical Characteristics 16%
• Cancer Diagnosis 16%
• Genetic Markers 16%
• Routine Analysis 16%
• Proliferation Marker Ki-67 16%
• Age Distribution 16%
• P53 Protein 16%
• Operative Risk 16%
• Pathological Characteristics 16%
• Pathological Examination 16%
• Proliferation Marker 16%
• Sex Distribution 16%
• Nuclear Atypia 16%
• Diagnosis of Malignancies 16%
• Serous Cystadenoma 16%
• Cystadenoma 16%
• Am(III) 16%
• Cystadenocarcinoma 16%
• Papillary Structure 16%
• Serous Cystadenoma of the Pancreas 16%
• Ki-67 Protein 16%
• Histopathological Features 16%
• Surgically Treated 16%
• Prevalence Distribution 16%

Medicine and Dentistry

• Cancer 100%
• Cystic Neoplasm 100%
• Cystadenoma 50%
• Mucinous Cystadenocarcinoma 50%
• Neoplasm 33%
• Prevalence 33%
• Malignant Neoplasm 33%
• Metastatic Carcinoma 33%
• Primary Tumor 33%
• Clinical Method 16%
• Protein P53 16%
• Age Distribution 16%
• Surgical Risk 16%
• Nuclear Atypia 16%
• Sex Ratio 16%
• Mucinous Cystic Neoplasm 16%
• Ki-67 (Protein) 16%

Nursing and Health Professions

• Cystic Neoplasm 100%
• Cystadenocarcinoma 50%
• Cystadenoma 50%
• Prevalence 33%
• Malignant Neoplasm 33%
• Neoplasm 33%
• Primary Tumor 33%
• Surgical Risk 16%
• Protein P53 16%
• Mucinous Cystic Neoplasm 16%